Evidence map›Paper›PMID 31987052›Full record

ArticleBMC medicine2020

Using health facility-based serological surveillance to predict receptive areas at risk of malaria outbreaks in elimination areas.

Henry Surendra, Supargiyono, Riris A Ahmad, Rizqiani A Kusumasari, Theodola B Rahayujati, Siska Y Damayanti, Kevin K A Tetteh, Chetan Chitnis, Gillian Stresman, Jackie Cook and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Serology reveals comparable patterns in the transmission intensities ofFrontiers in cellular and infection microbiology · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Using Serological Markers for the Surveillance ofPathogens (Basel, Switzerland) · 2023
    Article
  13. Serosurveillance of SARS-CoV-2 in Welsh Blood Donors: Establishment of the surveillance system and results up to November 2022.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Henry SurendraDepartment of Infection Biology, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK. henry-surendra.saridah@lshtm.ac.uk.ORCID 0000-0002-6029-0623
SupargiyonoCentre for Tropical Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Jl. Medika, Yogyakarta, 55281, Indonesia.
Riris A AhmadCentre for Tropical Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Jl. Medika, Yogyakarta, 55281, Indonesia.
Rizqiani A KusumasariCentre for Tropical Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Jl. Medika, Yogyakarta, 55281, Indonesia.
Theodola B RahayujatiDistrict Health Office of Kulon Progo, Jln. Suparman No 1, Wates, 55611, Indonesia.
Siska Y DamayantiDistrict Health Office of Kulon Progo, Jln. Suparman No 1, Wates, 55611, Indonesia.
Kevin K A TettehDepartment of Infection Biology, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK.
Chetan ChitnisInstitut Pasteur, Paris, France.
Gillian StresmanDepartment of Infection Biology, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK.
Jackie CookMRC Tropical Epidemiology Group, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK.
Chris DrakeleyDepartment of Infection Biology, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK.
London School of Hygiene & Tropical Medicine · GBUniversitas Gadjah Mada · IDInstitut Pasteur · FR

Funding

Indonesia Endowment Fund for Education (Lembaga Pengelola Dana Pendidikan, Indonesia) 20151022084537Medical Research Council MR/R010161/1
6 · The paper itself

Abstract

backgroundIn order to improve malaria burden estimates in low transmission settings, more sensitive tools and efficient sampling strategies are required. This study evaluated the use of serological measures from repeated health facility-based cross-sectional surveys to investigate Plasmodium falciparum and Plasmodium vivax transmission dynamics in an area nearing elimination in Indonesia.

methodsQuarterly surveys were conducted in eight public health facilities in Kulon Progo District, Indonesia, from May 2017 to April 2018. Demographic data were collected from all clinic patients and their companions, with household coordinates collected using participatory mapping methods. In addition to standard microscopy tests, bead-based serological assays were performed on finger-prick bloodspot samples from 9453 people. Seroconversion rates (SCR, i.e. the proportion of people in the population who are expected to seroconvert per year) were estimated by fitting a simple reversible catalytic model to seroprevalence data. Mixed effects logistic regression was used to examine factors associated with malaria exposure, and spatial analysis was performed to identify areas with clustering of high antibody responses.

resultsParasite prevalence by microscopy was extremely low (0.06% (95% confidence interval 0.03-0.14, n = 6) and 0 for P. vivax and P. falciparum, respectively). However, spatial analysis of P. vivax antibody responses identified high-risk areas that were subsequently the site of a P. vivax outbreak in August 2017 (62 cases detected through passive and reactive detection systems). These areas overlapped with P. falciparum high-risk areas and were detected in each survey. General low transmission was confirmed by the SCR estimated from a pool of the four surveys in people aged 15 years old and under (0.020 (95% confidence interval 0.017-0.024) and 0.005 (95% confidence interval 0.003-0.008) for P. vivax and P. falciparum, respectively). The SCR estimates in those over 15 years old were 0.066 (95% confidence interval 0.041-0.105) and 0.032 (95% confidence interval 0.015-0.069) for P. vivax and P. falciparum, respectively.

conclusionsThese findings demonstrate the potential use of health facility-based serological surveillance to better identify and target areas still receptive to malaria in an elimination setting. Further implementation research is needed to enable integration of these methods with existing surveillance systems.

Indexed as

Disease OutbreaksSeroepidemiologic StudiesAdultCluster AnalysisCross-Sectional StudiesDiagnostic Tests, RoutineFemaleHealth FacilitiesHumansIndonesiaLogistic ModelsMalariaMalaria, FalciparumMalaria, VivaxMaleMicroscopyEliminationMalariaMappingSerologySurveillance

Identifiers

PMID31987052
PMCPMC6986103
OpenAlexW3013394899

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.